Please login to the form below

Not currently logged in
Email:
Password:

Clovis

This page shows the latest Clovis news and features for those working in and with pharma, biotech and healthcare.

Lynparza significantly delays disease progression as first-line treatment in prostate cancer

Lynparza significantly delays disease progression as first-line treatment in prostate cancer

Last year, they entered the prostate cancer setting with the approval of Clovis’ Rubraca (rucaparib) and AstraZeneca and Merck/MSD’s Lynparza (olaparib).

Latest news

More from news
Approximately 8 fully matching, plus 39 partially matching documents found.

Latest Intelligence

  • Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe

    Jacob Plieth at Vantage recently highlighted this trend, with companies like Tesaro, Clovis Oncology and Acadia failing to meet revenue expectations for their new launches.

  • Deal Watch table for November 2013 Deal Watch table for November 2013

    500. Clovis / Servier. Licence. Servier licenses lucitanib excluding China, Japan and the US. ... 425. EOS /Clovis. Acquisition. Lucitanib for FGF aberrant breast cancer. 420.

  • Pharma deals during November 2013 Pharma deals during November 2013

    It was clearly busy times at Clovis this month with two major announcements, firstly the acquisition of the privately owned Italian company, Ethical Oncology Science (EOS) for an upfront payment of ... In addition, Clovis is to pay $65m on the FDA

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

  • Roche's Julie Warner joins Boyds Roche's Julie Warner joins Boyds

    She has previously held positions at Clovis Oncology UK, Genzyme and Gregory Fryer Associate, and was most recently senior regulatory programme manager at Roche.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides powerful, insight-driven, healthcare communication services to the pharmaceutical industry across the globe, with a focus...

Latest intelligence

The communication challenge of helping he next generation to be healthier
As the pressure on the health service increases the health of the next generation is vital for everyone. How do we show positive attitudes and change behaviour while future proofing...
Are we losing sight of what the democratisation of healthcare really looks like?
We have a core responsibility as healthcare communicators to consistently drive for better inclusion, engagement and compliance. What does the ‘democratisation of healthcare’ really look like?...
William Kilgallon
How the Royal Society’s EiR programme can help to drive UK innovation
...